The global nephrology devices market is gaining momentum as kidney-related disorders rise worldwide. With increasing geriatric populations and higher cases of chronic kidney disease (CKD), the demand for nephrology devices such as dialysis instruments and lithotripters is projected to grow steadily over the next decade.

The nephrology devices market was valued at USD 6.35 Billion in 2024 and is expected to expand from USD 6.79 Billion in 2025 to USD 11.49 Billion by 2033, registering a CAGR of 6.8% during 2025–2033. Rising kidney disease prevalence and technological advancements in treatment devices are fueling this growth.

📥 Download Sample

Key Market Insights

  • North America leads the market and is expected to grow at a CAGR of 4.0%, driven by the high prevalence of CKD and the presence of key players such as Baxter and Becton Dickinson.

  • Asia-Pacific is projected to grow at the fastest pace, recording a CAGR of 5.0%, supported by large patient pools in China and India, rising healthcare spending, and growing awareness.

  • Europe maintains a strong position due to established manufacturers like Dornier MedTech GmbH and B. Braun AG, alongside increasing adoption of advanced dialysis solutions.

  • Dialysis Instruments dominate the market and are forecasted to grow at a CAGR of 4.6%, owing to rising CKD cases and wider adoption in developing economies.

Growth Drivers

  • Surge in Geriatric Population: Older adults face higher risks of kidney failure, pushing demand for dialysis and other nephrology devices.

  • Rising Prevalence of Renal Disorders: With around 37 million adults in the U.S. affected by CKD and nearly 500,000 with polycystic kidney disease, the need for treatment devices continues to climb.

  • High Growth Potential in Emerging Markets: Countries like India, China, and those in LAMEA offer strong opportunities due to expanding healthcare infrastructure and large patient bases.

Restraining Factors

  • High Equipment Costs: Advanced dialysis machines can cost over USD 32,000, limiting adoption in low-income regions.

  • Product Recalls: Frequent recalls have affected confidence in certain devices, posing a challenge for market expansion.

Recent Developments

  • November 2023: DaVita Clinical Research presented five new kidney health studies at ASN Kidney Week, highlighting progress in health equity and hospitalization reduction.

  • August 2023: Quanta Dialysis Technologies received FDA clearance for its updated hemodialysis device, expanding treatment options.

Key Players in the Nephrology Devices Market

  • Medtronic

  • Coloplast

  • Boston Scientific Corporation

  • ConvaTec Group

  • B. Braun AG

  • Hollister

  • Teleflex Inc.

  • Baxter

  • Fresenius Medical Care

  • Asahi Kasei Corp.

  • Cook Group

  • C. R. Bard Inc.

  • Terumo Corporation

  • NxStage Medical Inc.

  • Nipro Corporation

Conclusion

The nephrology devices market is on track for steady growth, driven by an aging population, increasing kidney disease cases, and expanding healthcare systems across developing economies. While high costs and product recalls remain barriers, the long-term opportunities in Asia-Pacific and LAMEA present strong growth prospects for device manufacturers and healthcare providers alike.

About Us:

Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:

Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/